Europe

In Russia, the Chestny ZNAK system represents a comprehensive national track and trace framework designed to ensure pharmaceutical authenticity and combat counterfeit medications. Established under Federal Law No. 425-FZ in December 2017, this robust regulatory system has undergone phased implementation since 2019, creating one of the world's most stringent pharmaceutical traceability networks aimed at protecting public health and ensuring supply chain integrity.

In Kazakhstan, the Information System for Marking and Traceability of Goods (IS MPT) serves as the country's comprehensive framework for ensuring pharmaceutical integrity. Operated by Kazakhtelecom JSC, this centralized digital system employs advanced tracking technologies to combat counterfeit medications, enhance supply chain transparency, and safeguard public health across the nation's pharmaceutical landscape.

Armenia stands at the forefront of pharmaceutical supply chain modernization through its comprehensive e-Mark electronic marking system. As a member of the Eurasian Economic Union (EAEU), Armenia is strategically developing its track and trace regulatory framework to align with international standards while ensuring robust protection against counterfeit medicines. The country's phased approach to implementation demonstrates a commitment to building a transparent and secure pharmaceutical ecosystem that safeguards public health through advanced digital oversight mechanisms.

Serbia has established a sophisticated pharmaceutical regulation system that prioritizes patient safety through advanced traceability measures and anti-counterfeiting protocols. Built upon the foundation of the Serbian Drugs Law of 1993 and aligned with European standards, Serbia's regulatory framework ensures comprehensive monitoring of pharmaceutical products from manufacturer to patient, creating a robust defense against falsified medicines while enabling rapid response capabilities.